Carolyn Cross – Chairman and Chief Executive Officer
Chartered Financial Analyst
MBA – York University
Ms. Cross was one of the initial founders and financial supporters of Ondine Biomedical Inc. in 1999 and currently serves as the Chairman of the board and Chief Executive Officer the Company. Ms. Cross has over 18 years direct experience working with early stage companies and has 25 years experience with public market securities. Previously, Ms. Cross was responsible for managing pension, pooled, mutual and private client funds as a Vice President with Royal Bank Investment Management Inc., the fund management arm of the Royal Bank of Canada. She currently sits on the boards of a number of companies including Periowave Dental Technologies, Inc., OrGenX Biopharma Corp., and Sinuwave Technologies Corp, and sits on the Advisory Board of the McGill University Dental School. Ms Cross is a member of the Women’s Presidents Organization, the International Women’s Forum, the Toronto Society of Financial Analysts, the Courthill and Cherie Blair Foundations, and the Association for Professionals In Infection Control and Epidemiology. Ms Cross is the Founder of OrGenX Biopharma Corporation, a WEConnect certified company.
Nicolas G. Loebel – Chief Technology Officer and President
Ph.D Biomedical Engineering – University of Washington
MSE Biomedical Engineering – University of Washington
BSAA Aeronautical Engineering – University of Washington
Dr. Loebel serves as President and Chief Technology Officer to the Company, specializing in product research and development, photochemistry, systems integration, and cross-functional team building. His research focus has centered on novel photochemistries, rheological modeling of periodontal disease and tooth mobility, fiber optic waveguide propagation theory, evanescent coupling and the applications of optical fibers to interferometric sensors. He has experience in dental and medical product development and manufacturing, corporate management and business development in public and private market environments. He has authored numerous publications and patents and lectures regularly on antimicrobial photodynamics around the world.
William S. Harper – Chief Financial Officer, Vice President Finance & Corporate Secretary
MBA – York University
Mr. Harper is a professional accountant with more than 25 years experience in corporate finance and administration, including senior management positions with public companies listed in both Canada and the United States, primarily in the mining and high technology industries. Prior to joining Ondine Biomedical, he was the chief financial officer and corporate secretary of several public companies listed on the TSX Venture Exchange.